Cargando…

Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.

Small cell bronchial carcinoma (SCC) xenografts with differing sensitivity to cyclophosphamide (CY) were investigated using a variety of techniques. Two xenografts (HX78 and HX88) were relatively sensitive to CY, one xenograft (HX72) was inherently resistant to CY and a fourth xenograft (HX78Cy) was...

Descripción completa

Detalles Bibliográficos
Autores principales: Berman, R., Gusterson, B., Steel, G. G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1985
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977064/
https://www.ncbi.nlm.nih.gov/pubmed/2581600
_version_ 1782135182776598528
author Berman, R.
Gusterson, B.
Steel, G. G.
author_facet Berman, R.
Gusterson, B.
Steel, G. G.
author_sort Berman, R.
collection PubMed
description Small cell bronchial carcinoma (SCC) xenografts with differing sensitivity to cyclophosphamide (CY) were investigated using a variety of techniques. Two xenografts (HX78 and HX88) were relatively sensitive to CY, one xenograft (HX72) was inherently resistant to CY and a fourth xenograft (HX78Cy) was a CY induced resistant subline of HX78 and was unstable when maintained without CY exposure. Conventional light microscopy, cytology and electron microscopy examination of the xenografts revealed appearances consistent with SCC. An antikeratin antibody demonstrated the presence of keratin in the inherent and the induced resistant xenografts (and in the unstable revertant) but not in the two sensitive xenografts; the presence of keratin suggested squamous differentiation. Monolayer culture morphology of the sensitive HX78 and the unstable revertant was anchorage independent with the cells forming floating aggregates; the induced resistant subline of this xenograft (HX78Cy) showed, by contrast, flattened, angular adherent cells. Beta HCG production was detected in the monolayer culture supernatant of sensitive HX78 cells; the level of production of beta HCG was increased in the induced resistant HX78Cy cells. Karyotype and flow cytometry studies were also performed. The morphological responses of small cell lung cancer to treatment are discussed. IMAGES:
format Text
id pubmed-1977064
institution National Center for Biotechnology Information
language English
publishDate 1985
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19770642009-09-10 Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer. Berman, R. Gusterson, B. Steel, G. G. Br J Cancer Research Article Small cell bronchial carcinoma (SCC) xenografts with differing sensitivity to cyclophosphamide (CY) were investigated using a variety of techniques. Two xenografts (HX78 and HX88) were relatively sensitive to CY, one xenograft (HX72) was inherently resistant to CY and a fourth xenograft (HX78Cy) was a CY induced resistant subline of HX78 and was unstable when maintained without CY exposure. Conventional light microscopy, cytology and electron microscopy examination of the xenografts revealed appearances consistent with SCC. An antikeratin antibody demonstrated the presence of keratin in the inherent and the induced resistant xenografts (and in the unstable revertant) but not in the two sensitive xenografts; the presence of keratin suggested squamous differentiation. Monolayer culture morphology of the sensitive HX78 and the unstable revertant was anchorage independent with the cells forming floating aggregates; the induced resistant subline of this xenograft (HX78Cy) showed, by contrast, flattened, angular adherent cells. Beta HCG production was detected in the monolayer culture supernatant of sensitive HX78 cells; the level of production of beta HCG was increased in the induced resistant HX78Cy cells. Karyotype and flow cytometry studies were also performed. The morphological responses of small cell lung cancer to treatment are discussed. IMAGES: Nature Publishing Group 1985-05 /pmc/articles/PMC1977064/ /pubmed/2581600 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Berman, R.
Gusterson, B.
Steel, G. G.
Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.
title Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.
title_full Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.
title_fullStr Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.
title_full_unstemmed Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.
title_short Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.
title_sort resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977064/
https://www.ncbi.nlm.nih.gov/pubmed/2581600
work_keys_str_mv AT bermanr resistancetoalkylatingagentsandtumourdifferentiationinxenograftsofsmallcelllungcancer
AT gustersonb resistancetoalkylatingagentsandtumourdifferentiationinxenograftsofsmallcelllungcancer
AT steelgg resistancetoalkylatingagentsandtumourdifferentiationinxenograftsofsmallcelllungcancer